Document Preview Unavailable
Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Achiron Anat; Mandel Mathilda; Dreyer-Alster Sapir; Harari, Gil; Magalashvili, David; et al. Therapeutic Advances in Neurological Disorders Vol. 14, (Jan 2021).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library




